Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intracellular mechanisms of TRAIL and its role in cancer therapy.

× No keyword cloud information.

18 in total

1. Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo.

Authors: Jisun Lee; Seul Lee; Andriy Synytsya; Peter Capek; Chang Won Lee; Ji Won Choi; Sarang Cho; Woo Jung Kim; Yong Il Park
Journal: Mar Biotechnol (NY) Date: 2018-08-29 Impact factor: 3.619

2. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK.

Authors: Sahdeo Prasad; Vivek R Yadav; Ramaswamy Kannappan; Bharat B Aggarwal
Journal: J Biol Chem Date: 2010-12-14 Impact factor: 5.157

3. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma.

Authors: Tamer E Fandy; Sharmila Shankar; Douglas D Ross; Edward Sausville; Rakesh K Srivastava
Journal: Neoplasia Date: 2005-07 Impact factor: 5.715

Review 4. TRAIL/Apo-2L: mechanisms and clinical applications in cancer.

Authors: R K Srivastava
Journal: Neoplasia Date: 2001 Nov-Dec Impact factor: 5.715

5. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.

Authors: Arnon P Kater; Frank Dicker; Massimo Mangiola; Kate Welsh; Richard Houghten; John Ostresh; Adel Nefzi; John C Reed; Clemencia Pinilla; Thomas J Kipps
Journal: Blood Date: 2005-05-24 Impact factor: 22.113

6. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors: Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal: J Mol Signal Date: 2010-08-18

7. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.

Authors: Fu-Liang Bai; Yin-Hang Yu; Hui Tian; Gui-Ping Ren; Hui Wang; Bing Zhou; Xiao-Hui Han; Qing-Zhong Yu; De-Shan Li
Journal: Cancer Biol Ther Date: 2014-06-27 Impact factor: 4.742

8. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.

Authors: Sharmila Shankar; Imtiaz Siddiqui; Rakesh K Srivastava
Journal: Mol Cell Biochem Date: 2007-07-17 Impact factor: 3.396

9. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).

Authors: Pushpa Saranya Kollipara; Heon Sang Jeong; Sang Bae Han; Jin Tae Hong
Journal: Br J Pharmacol Date: 2013-03 Impact factor: 8.739

10. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.

Authors: Sanjit K Roy; Rakesh K Srivastava; Sharmila Shankar
Journal: J Mol Signal Date: 2010-07-19